Irlanti - englanti - HPRA (Health Products Regulatory Authority)

helsinn birex therapeutics ltd - ciprofloxacin hydrochloride - tablets - 250 milligram

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

helsinn birex therapeutics ltd - ciprofloxacin hydrochloride - tablets - 500 milligram

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

helsinn birex therapeutics ltd - ciprofloxacin hydrochloride - tablets - 750 milligram

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

sinclair is pharma limited - ciprofloxacin hydrochloride - tablets - 100 milligram

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

sinclair is pharma limited - ciprofloxacin hydrochloride - tablets - 750 milligram

Filippiinit - englanti - FDA (Food And Drug Administration)

medical generics mktg co., - ciprofloxacin (as hydrochloride) - tablet, film coated - 500mg

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ciprofloxacin 2 mg/ml (equates to ciprofloxacin lactate 2.54 mg/ml in the final formulation) - solution for infusion - 2 mg/ml - active: ciprofloxacin 2 mg/ml (equates to ciprofloxacin lactate 2.54 mg/ml in the final formulation) excipient: hydrochloric acid lactic acid sodium chloride water for injection - infections of the lower respiratory tract. in the treatment of outpatients with pneumonia due to pneumococcus, ciprofloxacin should not be used as a medicine of first choice. ciprofloxacin can be regarded as a suitable treatment for pneumonias caused by klebsiella, enterobacter, proteus, e. coli, pseudomonas, haemophilus, branhamella, legionella, and staphylococcus.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - mycophenolate mofetil 500mg;   - film coated tablet - 500 mg - active: mycophenolate mofetil 500mg   excipient: croscarmellose sodium hyprolose magnesium stearate microcrystalline cellulose opadry purple 03b50110 povidone purified talc - for the prophylaxis of acute organ rejection in patients receiving allogeneic renal transplants.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ciprofloxacin 10 g - oral suspension - 100 mg/ml - active: ciprofloxacin 10 g excipient: hypromellose magnesium stearate methacrylic acid copolymer polysorbate 20 povidone lecithin medium-chain triglycerides purified water strawberry flavour 52312 ah strawberry flavour 54267ah sucrose

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ciprofloxacin 58.22 mg/ml equivalent to 50 mg/ml ciprofloxacin - oral suspension - 50 mg/ml - active: ciprofloxacin 58.22 mg/ml equivalent to 50 mg/ml ciprofloxacin excipient: hypromellose magnesium stearate methacrylic acid copolymer polysorbate 20 povidone lecithin medium-chain triglycerides purified water strawberry flavour 52312 ah strawberry flavour 54267ah sucrose